Analysts Expect IntriCon Co. (IIN) Will Post Quarterly Sales of $30.30 Million
Equities research analysts predict that IntriCon Co. (NASDAQ:IIN) will announce sales of $30.30 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for IntriCon’s earnings. IntriCon reported sales of $22.23 million during the same quarter last year, which indicates a positive year over year growth rate of 36.3%. The business is scheduled to issue its next earnings report on Monday, February 11th.
According to Zacks, analysts expect that IntriCon will report full year sales of $115.93 million for the current financial year, with estimates ranging from $115.90 million to $115.96 million. For the next fiscal year, analysts anticipate that the business will report sales of $138.17 million, with estimates ranging from $136.50 million to $139.84 million. Zacks’ sales calculations are a mean average based on a survey of sell-side research analysts that follow IntriCon.
IntriCon (NASDAQ:IIN) last released its quarterly earnings results on Monday, November 5th. The technology company reported $0.22 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.20 by $0.02. IntriCon had a return on equity of 13.06% and a net margin of 4.82%. The business had revenue of $30.13 million during the quarter, compared to analyst estimates of $30.23 million.
Shares of IntriCon stock opened at $33.16 on Friday. IntriCon has a 52 week low of $16.70 and a 52 week high of $76.80. The stock has a market capitalization of $296.73 million, a PE ratio of 114.34, a price-to-earnings-growth ratio of 3.97 and a beta of 0.95.
Large investors have recently bought and sold shares of the stock. First Mercantile Trust Co. purchased a new stake in shares of IntriCon in the third quarter worth about $159,000. GSA Capital Partners LLP purchased a new stake in shares of IntriCon in the second quarter worth about $226,000. Rhumbline Advisers purchased a new stake in shares of IntriCon in the second quarter worth about $232,000. CAPROCK Group Inc. purchased a new stake in shares of IntriCon in the third quarter worth about $251,000. Finally, Los Angeles Capital Management & Equity Research Inc. purchased a new stake in shares of IntriCon in the third quarter worth about $270,000. Institutional investors own 59.51% of the company’s stock.
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets.
Featured Article: Exchange-Traded Funds (ETFs)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.